MIP Pharma Group
@mip-pharma.de
MiP Pharma Unternehmensgruppe ist ein international aufgestelltes mittelständisches Pharmaunternehmen mit eigener Entwicklung und auch Produktion.
MIP Pharma Group's Company Logos
MIP Pharma Group's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0A66C2
Science Blue
10, 102, 194
210, 90, 40
95, 47, 0, 24
#E6DBB9
Double Spanish White
230, 219, 185
45, 47, 81
0, 5, 20, 10
#06357A
Catalina Blue
6, 53, 122
216, 91, 25
95, 57, 0, 52
About MIP Pharma Group
MiP Pharma is an internationally positioned medium-sized pharmaceutical company with its own development and production capabilities. With over 65 years of company history, MiP Pharma is committed to providing reliable and sustainable pharmaceutical supply in Germany and Europe. Our team of 270 professionals focuses on ensuring a secure and high-quality drug supply for our customers, in line with our mission.
Since 1970, we have been manufacturing pharmaceuticals in our modern, GMP-certified production facilities at our locations in Saarland, Germany. We produce medicines for our own distribution as well as provide contract manufacturing services for other pharmaceutical companies. Our distribution focus is on the hospital sector, targeted specialist groups, and especially dentists.
Our main markets include Germany, Poland, and other Eastern European markets, with MiP Pharma currently operating in 17 locations outside of Germany. We take pride in our qualified employees, state-of-the-art production facilities, and efficient processes, as well as fostering a culture of respect and performance. These factors have contributed to our long-standing success.
Recognized for our high delivery reliability and customer orientation, we have been awarded multiple times as the Best Pharmaceutical Supplier in the hospital sector in Germany. In late 2020, MiP Pharma Unternehmensgruppe was acquired by Berlin-based capiton AG, with the company now pursuing a forward-looking strategy for growth in specialized markets and portfolios. This involves ongoing modernization and expansion of production facilities, as well as optimizing all processes to reduce costs.
In the 2021/22 financial year, MiP Pharma achieved a record sales growth of approximately 15%, reaching around 50 million euros in revenue. For the latest information about us, please visit our website, and for inquiries and feedback regarding our products, you can find our contact details there. If you are interested in joining our team and believe you can contribute to our vision, we encourage you to apply to our current job openings or submit an unsolicited application.
Data protection is of utmost importance to us as a healthcare company, and you can find our privacy policy on our website to learn more about how we protect your information
Company type
Public Company
Year founded
1955
Company size
201-500 employees
